Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Umbilical cord blood serum-derived extracellular vesicles for androgenic alopecia
IRCT20221130056672N1Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of platelet-rich plasma and minoxidil in androgenetic alopecia (AGA) (3 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Hair follicle density per surface unit and Hair follicle shaft thickness. Started Dec 2023; status: completed.
02
Drugs
platelet-rich plasmaminoxidil
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on IRCT20221130056672N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221130056672N1.